...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Presentation at AACR Meeting April 10-15
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"How far do we think zen3694 is from being an approved therapy for those conditions"

hopefully close enough to the point it gives some Pharma(s) the feeling/need that it's time to take full control of this ship.

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply